Dr. Kelly K. Kempe, MD

Dr. Kempe practices at Board of Regents of the University of Oklahoma OU Physicians Tulsa in Tulsa, Oklahoma.

Dr. Kempe's NPI, 1972763704, was assigned on June 16, 2008. Dr. Kempe graduated from University of Washington School of Medicine in 2008. Dr. Kempe holds Oklahoma license 34365.

Dr. Kempe's primary practice is Board of Regents of the University of Oklahoma OU Physicians Tulsa, at 4502 E 41st S St, Tulsa, OK 74135 in Tulsa County. The practice phone is (918) 660-3632.

Dr. Kempe's primary practice is Board of Regents of the University of Oklahoma OU Physicians Tulsa in Tulsa, Oklahoma. Dr. Kempe is also affiliated with Saint Francis Hospital. The medical group on file is Muscogee Nation Department of Health. Dmand AI also links Dr. Kempe to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kempe practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Kempe's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Kempe is licensed in Oklahoma.

CMS data shows 189 Medicare services from Dr. Kempe across 6 procedure codes in 2024, for 135 Medicare patients. Medicare paid $13,285 for them.

CMS counts 135 Medicare patients who saw Dr. Kempe in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 32% are also on Medicaid. Their average risk score is 3.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kempe's median patient age at 69, with 49% women.

In 2024, Dr. Kempe wrote 56 Medicare Part D claims for 21 patients. 80% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $409 in total drug cost. In 2022, CMS named 20 claims across 1 drug.

Dr. Kempe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Kempe, published from 2014 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Peripheral Arterial Disease, Amputation, Surgical and Lower Extremity. Dr. Kempe has published most often in Ann Vasc Surg. Dr. Kempe's most frequent co-authors are Peter Richard Nelson, MD, MS, Viraj Pandit, MD and Hyein Kim, MD.

Dmand AI links Dr. Kempe to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 34 general payments to Dr. Kempe from 12 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 75% of the total. Silk Road Medical, Inc. paid the most, $1,452.

Dr. Kempe graduated from University of Washington School of Medicine in 2008.